Abstract:Abstract RNA has emerged as a revolutionary and important tool in the battle against emerging infectious diseases, with roles extending beyond its applications in vaccines, in which it is used in the response to the COVID-19 pandemic. Since their development in the 1990s, RNA interference (RNAi) therapeutics have demonstrated potential in reducing the expression of disease-associated genes. Nucleic acid‐based therapeutics, including RNAi therapies, that degrade viral genomes and rapidly adapt to viral mutations, have emerged as alternative treatments. RNAi is a robust technique frequently employed to selectively suppress gene expression in a sequence-specific manner. The swift adaptability of nucleic acid‐based therapeutics such as RNAi therapies endows them with a significant advantage over other antiviral medications. For example, small interfering RNAs (siRNAs) are produced on the basis of sequence complementarity to target and degrade viral RNA, a novel approach to combat viral infections. The precision of siRNAs in targeting and degrading viral RNA has led to the development of siRNA-based treatments for diverse diseases. However, despite the promising therapeutic benefits of siRNAs, several problems, including impaired long-term protein expression, siRNA instability, off-target effects, immunological responses, and drug resistance, have been considerable obstacles to the use of siRNA-based antiviral therapies. This review provides an encompassing summary of the siRNA-based therapeutic approaches against viruses while also addressing the obstacles that need to be overcome for their effective application. Furthermore, we present potential solutions to mitigate major challenges.

RNA interference and its therapeutic potential against HIV infection

Antiviral Stratagems against HIV-1 Using RNA Interference (RNAi) Technology

Lentiviral Delivery of RNAi Effectors Against HIV-1

CRISPR therapy towards an HIV cure

The discovery and development of RNA-based therapies for treatment of HIV-1 infection

Small interfering RNA (siRNA)-based therapeutic applications against viruses: principles, potential, and challenges

siRNA, miRNA and HIV: promises and challenges

SiRNAs as antiviral drugs – Current status, therapeutic potential and challenges.

CRISPR-Cas9 potential in treating HIV/AIDS

RNAi-inducing lentiviral vectors for anti-HIV-1 gene therapy

Antiviral RNAi therapy: emerging approaches for hitting a moving target

RNA Interference as a Prospective Tool for the Control of Human Viral Infections

Strategies for Inhibiting Function of HIV-1 Accessory Proteins: A Necessary Route to AIDS Therapy?

Simultaneously Inhibition of Hiv and Hbv Replication Through A Dual Small Interfering Rna Expression System

Opportunities for treating chronic hepatitis B and C virus infection using RNA interference

Exploring the potential of structural modeling and molecular docking for efficient siRNA screening: A promising approach to Combat viral mutants, with a focus on HIV-1

Treatment strategies for HIV infection with emphasis on role of CRISPR/Cas9 gene: Success so far and road ahead

Small-molecule Inhibitors of HIV-1 Reverse Transcriptase-Associated Ribonuclease H Function: Challenges and Recent Developments

The Role of MicroRNAs in HIV Infection

Therapeutic potential of RNA interference: a new molecular approach to antiviral treatment for hepatitis C

Updates on CRISPR-based gene editing in HIV-1/AIDS therapy